Interim Reports

Latest Reports

  • Cell therapy production in a clean-room like environment

    Interim Report 2 2021/22

    Strong sales growth for the 3rd consecutive quarter. Recent advancements in regenerative medicine create additional growth potential in clinical applications for the company.

    Learn more …
  • Blue cells on white background showing a closing cell gap of a wound healing assay

    Interim Report 1 2021/22

    The strategic shift of sales and marketing continues to prove itself. Despite being a “slow summer quarter”, sales during May – July surpassed sales during any previous quarter.

    Learn more …
  • LCI-lp_banner

    Year-end Report 2020/21

    The strategic shift to focus on digital sales & marketing has been successful, reflected in the sales increase during the latter part of the fiscal year.

    Learn more …
  • Closeup of HoloMonitor's objective

    Interim Report 3 (2020-11-01 – 2021-01-31)

    The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.

    Learn more …

Older Reports